Mainland China Global News & Press Release Distribution

Mainland China

All
APAC

Point of convergence

BEIJING, April 12, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: Point of convergence Yunnan, a province in Southwest China, shares borders and cultural affinity withSoutheast Asia, and ancient trade routes such as the ...

2024-04-12 23:26 1757

【2024 AACR Late Breaking Research】TransThera announces clinical data of tinengotinib to treat patients with advanced solid tumors harboring actionable FGFR1-3 alterations

NANJING, China and GAITHURSBURG, Md., April 12, 2024 /PRNewswire/ -- TransThera Sciences, a clinical-stage biopharmaceutical company focused on inventing differentiated drugs for global patients, announced the poster presentation at the 2024 American Association for Cancer Research (AACR) to disc...

2024-04-12 21:00 1622

EZGO Enters into an RMB13 Million Procurement Agreement for Sale of Security Patrol Robots and Platform

CHANGZHOU, China, April 12, 2024 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or "we," "our," or the "Company"), a leading short-distance transportation solutions provider inChina, today announced that it entered into a procurement agreement (the "Procurement Agreement") with Ha...

2024-04-12 20:00 3425

NaaS Technology Commits to Gender Equality and Women's Empowerment by Signing WEPs

BEIJING, April 12, 2024 /PRNewswire/ -- NaaS Technology (NASDAQ:NAAS) , the first U.S. listed EV charging service company inChina, recently announced its new status as a global member of the United NationsWomen's Empowerment Principles (WEPs). The company pledges to advance gender equality and wo...

2024-04-12 19:19 1662

NewLink Included Again in Global Unicorn Index by Hurun Research Institute

BEIJING, April 12, 2024 /PRNewswire/ -- On April 9, the Hurun Research Institute released the Global Unicorn Index 2024 inGuangzhou, a ranking of the world's start-ups founded in the 2000s, worth at least a billion dollars and not yet listed on a public exchange. NewLink, with its successful dig...

2024-04-12 19:18 1581

ATRenew Inc. Files 2023 Annual Report on Form 20-F

SHANGHAI, April 12, 2024 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced the filing of its annual report on Form 20-F for the fiscal year endedDecember 31...

2024-04-12 18:18 2662

Baidu to Report First Quarter 2024 Financial Results on May 16, 2024

BEIJING, April 12, 2024 /PRNewswire/ -- Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu" or the "Company"), a leading AI company with a strong internet foundation, today announced that it will report its financial results for the First Quarter 2024 endedMarch ...

2024-04-12 17:00 1570

Appotronics Showcases its Pioneering ALPD Laser Projection Technology at CinemaCon 2024

SHENZHEN, China, April 12, 2024 /PRNewswire/ -- The international cinema industry conference, CinemaCon 2024 was held fromApril 9 to 11 at Caesars Palace,Las Vegas. As the largest and most important gathering for the worldwide motion picture theater industry, CinemaCon 2024 convened key players--...

2024-04-12 13:13 1469

Appotronics Showcases its Pioneering ALPD Laser Projection Technology at CinemaCon 2024

Zero-Emission Truck Developer Windrose Technology Completes US$110 Million Series B Financing

HONG KONG, April 11, 2024 /PRNewswire/ -- Electric heavy-duty truck developer Windrose Technology has announced completion of the second phase of its Series B financing, raising the total funding for this round toUS$110 million. The investors of this round of financing includeLondon-based HSBC, B...

2024-04-11 22:54 1181

Zero-Emission Truck Developer Windrose Technology Completes US$110 Million Series B Financing

Yum China CEO Joey Wat Releases Annual Letter to Stockholders

SHANGHAI, April 11, 2024 /PRNewswire/ -- Joey Wat, Chief Executive Officer of Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) released her annual letter to stockholders today together with the Company's 2023 Annual Report. The letter recappedYum China's strong 2...

2024-04-11 19:39 3221

Yatsen Regains Compliance with NYSE Minimum Price Continued Listing Criterion

GUANGZHOU, China, April 11, 2024 /PRNewswire/ -- Yatsen Holding Limited ("Yatsen" or the "Company") (NYSE: YSG), a leadingChina-based beauty group, today announced that it has received a letter from the New York Stock Exchange ("NYSE") datedApril 10, 2024 (the "April Letter"), notifying the Compa...

2024-04-11 17:00 2768

Xinzheng celebrates legacy of Yellow Emperor who led march to civilization

BEIJING, April 10, 2024 /PRNewswire/ -- A report from China Daily: Actors perform in the Yellow Emperor worship ceremony held in Xinzheng of Zhengzhou...

2024-04-11 11:43 1316

Xinzheng celebrates legacy of Yellow Emperor who led march to civilization

Development of exosome therapy to treat inflammatory bowel disease by VesiCURE Therapeutics

SUZHOU, China, April 10, 2024 /PRNewswire/ -- IBD, or Inflammatory Bowel Disease, traditionally more prevalent in developed nations, is increasingly observed in developing regions likeChina. It is a chronic, nonspecific inflammatory gastrointestinal disorder with an unknown etiology, characterize...

2024-04-10 21:15 1119

EZGO Announces 1-for-40 Reverse Share Split Effective April 12, 2024

CHANGZHOU, China, April 10, 2024 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or "we," "our," or the "Company"), a leading short-distance transportation solutions provider inChina, today announced that onMarch 22, 2024, its board of directors approved a reverse split of its ordi...

2024-04-10 19:00 982

Yum China's Unwavering Commitment to ESG Highlighted in 2023 Sustainability Report

SHANGHAI, April 10, 2024 /PRNewswire/ -- Yum China Holdings, Inc. (NYSE: YUMC and HKEX: 9987, "Yum China" or the "Company") today announced that it has published its seventh annual Sustainability Report. The report outlines the Company's achievements and ongoing progress towards its Environmental...

2024-04-10 17:00 1082

On the Fast Lane: NOVOSENSE's Ongoing Commitment to Automotive Chip Excellence

SHANGHAI, April 10, 2024 /PRNewswire/ -- Automobiles are undergoing increasing electrification and digitalization, from electric drive trains to immersive infotainment systems in the cockpit. NOVOSENSE, a pioneering force in the automotive chips, recently unveiled several groundbreaking products...

2024-04-10 15:49 878

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024

BEIJING and PARIS, April 10, 2024 /PRNewswire/ -- On March 15th, Biologics 2024 successfully concluded inLondon, with 650 pharmaceutical, biotechnology, and academic representatives and over 50 exhibitors engaging in high-level discussions on the latest innovations in biologics discovery and deve...

2024-04-10 14:19 891

Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024

Milesight Empowers Building Energy Retrofitting with loT Solutions and LoRaWAN® Technology

XIAMEN, China, April 9, 2024 /PRNewswire/ -- In today's world, where environmental consciousness is on the rise, the focus on energy efficiency is becoming paramount. Buildings, being one of the largest consumers of energy, offer a significant opportunity for reducing carbon footprints and conser...

2024-04-10 02:00 1729

The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements

SHENZHEN, China, April 9, 2024 /PRNewswire/ -- The Second International Conference on Single-cell and Spatial Omics (TICSSO-2), was held fromMarch 29th toApril 1st, 2024, in Shenzhen, China. The TICSSO was initiated by Prof. Xinghua Pan (Southern Medical University), Prof. Fuchou Tang (Peking Un...

2024-04-09 23:14 1405

BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3

SHANGHAI, April 9, 2024 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Phase 1 study of BC2027. BC2027, which is BioCity's second first-in-class antibody drug conjugate (...

2024-04-09 22:10 1106

1 ... 3 4 567 8 9 ... 794